SOLA CCCE HOME | ABOUT SOLA CCCE | OUR PEOPLE
Our Mission
We are dedicated to expanding equitable access to regenerative medicine clinical research for Los Angeles County Department of Health Services patients by bringing clinical trials directly to the communities where they receive care. Through the development of sustainable clinical trial infrastructure, a highly trained regenerative medicine workforce, and comprehensive community education on gene and cell therapies, CIRM SoLA CCCE seeks to improve access to innovative treatments, increase participation in clinical research, and ultimately aspiring to reduce health disparities in underserved populations.
Our Vision
A future in which regenerative medicine trial options are readily available to the underserved and diverse patients cared for through the LA County Department of Health Services. Along with enhanced access to research, this would ensure that research results are applicable to the broad population of patients cared for in this system.
With funding from the California Institute for Regenerative Medicine (CIRM), The Lundquist Institute launched the Christina Wang South Los Angeles Community Care Center of Excellence in Regenerative Medicine (SoLA CCCE) in March 2026. Christina Wang, MD was a Professor of Medicine, Assistant Dean at the David Geffen School of Medicine at UCLA, and Senior Associate Director for Clinical and Translational Science Institute and faculty member of the Division of Endocrinology, Department of Medicine, Harbor-UCLA Medical Center and The Lundquist Institute. Dr. Wang was a strong advocate for community-engaged research and for expanding access to clinical studies for underserved populations, helping ensure that scientific advances reached the communities most in need. That commitment was reflected in SoLA CCCE, expanding access to cutting-edge regenerative therapies while equipping local healthcare professionals with the knowledge and training to deliver them. Dr. Wang passed away in June 2026, and the program was later renamed in her honor to recognize her leadership and commitment to the community.
SoLA CCCE continues Dr. Wang’s work to expand access to regenerative medicine therapies for underserved communities across Los Angeles County. SoLA CCCE helps bring these opportunities directly into the community by expanding clinical trial access, supporting patients with navigation and education, strengthening community partnerships, training providers and community members, and connecting patients to statewide resources. SoLA CCCE is led by Program Director Lynda Polgreen, MD, and Associate Program Director Eric S. Daar, MD.
